Position in AZN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,244,286
-$70,579 QoQ
Shares Held
6,562
-1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#621
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEAVELL INVESTMENT MANAGEMENT, INC. holds $56,783,148 across 9 Drug Manufacturers - General names. AZN ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
74,935 | $18,856,643 | |
| 2 | LLY |
ELI LILLY & Co
|
9,341 | $11,203,876 | |
| 3 | JNJ |
Johnson & Johnson
|
40,591 | $10,308,896 | |
| 4 | AMGN |
Amgen Inc
|
17,935 | $6,494,622 | |
| 5 | MRK |
Merck & Co., Inc.
|
41,794 | $5,370,529 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,579 | $2,107,681 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
6,562 | $1,244,286 | |
| 8 | PFE |
Pfizer Inc
|
35,669 | $858,909 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,244,286 | 6,562 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,314,865 | 6,667 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||